These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 945382)

  • 1. [Prothrombin abnormality in the case of warfarin treatment, disseminated intravascular congulation syndrome and liver cirrhosis (author's transl)].
    Sakuragawa N
    Rinsho Byori; 1976 Apr; 24(4):279-80. PubMed ID: 945382
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antithrombin II. Immunological and biological levels in hepatic cirrhosis and in disseminated intravascular coagulation (author's transl)].
    Barrantes A; Fonseca JE
    Sangre (Barc); 1979; 24(6):1043-7. PubMed ID: 538557
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulation of blood coagulation factor levels in plasma.
    Karpatkin M; Karpatkin S
    Curr Top Hematol; 1985; 5():113-25. PubMed ID: 3882341
    [No Abstract]   [Full Text] [Related]  

  • 4. [Disturbances of hemostasis in patients with liver cirrhosis (author's transl)].
    Langiewicz J
    Przegl Lek; 1978; 35(2):307-10. PubMed ID: 652998
    [No Abstract]   [Full Text] [Related]  

  • 5. Disseminated intravascular coagulation in liver cirrhosis: fact or fiction?
    Ben-Ari Z; Osman E; Hutton RA; Burroughs AK
    Am J Gastroenterol; 1999 Oct; 94(10):2977-82. PubMed ID: 10520855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinopeptide A in liver cirrhosis: evidence against a major contribution of disseminated intravascular coagulation to coagulopathy of chronic liver disease.
    Mombelli G; Fiori G; Monotti R; Haeberli A; Straub PW
    J Lab Clin Med; 1993 Jan; 121(1):83-90. PubMed ID: 8426084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The therapeutic management of consumption coagulopathy in progressive liver cirrhosis: low-dosage heparin therapy (author's transl)].
    Fischer M; Falkensammer C; Klein HJ; Irsigler K; Bruneder H; Schnack H
    Wien Klin Wochenschr; 1976 Aug; 88(15):488-94. PubMed ID: 997529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Disseminated intravascular coagulation and lethal macrothrombosis in a patient with carcinoma of the biliary tract (author's transl)].
    Kunz F; Amor H; Hörtnagl H; Weiser G; Holzknecht F; Braunsteiner H
    Dtsch Med Wochenschr; 1974 Dec; 99(52):2643-7. PubMed ID: 4448152
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunological assay for plasma prothrombin--application to coagulation test and liver function test (author's transl)].
    Kitajima K; Okumura M
    Rinsho Ketsueki; 1979 Jun; 20(6):616-22. PubMed ID: 470154
    [No Abstract]   [Full Text] [Related]  

  • 10. Behaviour of protein C inhibitor in intravascular coagulation and liver disease.
    Francis RB; Thomas W
    Thromb Haemost; 1984 Aug; 52(1):71-4. PubMed ID: 6548588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Disseminated intravascular coagulation, with special reference to significance of various laboratory findings (author's transl)].
    Tsukada T; Watanabe T; Shinada S; Jinbo C
    Rinsho Byori; 1973 Nov; 21(11):900-6. PubMed ID: 4798407
    [No Abstract]   [Full Text] [Related]  

  • 12. [Intravascular coagulation of the blood in liver cirrhosis (a review of the literature)].
    Shelest LIu; Sushko EA; Shkapko VD; Shekhter IE; Ena IaM
    Vrach Delo; 1990 Aug; (8):44-7. PubMed ID: 2256285
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prothrombin (factor II) and prothrombin fragment 1+2 (F1+2)].
    Maruyama I
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():623-5. PubMed ID: 15658406
    [No Abstract]   [Full Text] [Related]  

  • 14. [The incidence of consumption coagulopathy in liver cirrhosis].
    Moreno Abadía V; Bermúdez García JM; Maldonado Martín A; Rico Irles J
    An Med Interna; 1989 Sep; 6(9):466-71. PubMed ID: 2562720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of several parameters of coagulation in liver cirrhosis: disseminated intravascular coagulation or pseudo-disseminated intravascular coagulation?].
    Petrella V; Parachini F; Rigotti T; Galimberti M; Cusumano S
    Minerva Med; 1988 Mar; 79(3):193-8. PubMed ID: 3362400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AICF and DIC in liver cirrhosis: expressions of a hypercoagulable state.
    Joist JH
    Am J Gastroenterol; 1999 Oct; 94(10):2801-3. PubMed ID: 10520824
    [No Abstract]   [Full Text] [Related]  

  • 17. [Coagulation disorders in patients with liver cirrhosis].
    Ihle E; Schimmelpfennig W
    Z Arztl Fortbild (Jena); 1983; 77(22):929-34. PubMed ID: 6659589
    [No Abstract]   [Full Text] [Related]  

  • 18. [Circulating levels of products of fibrinogen and fibrin monomer degradation in liver cirrhosis].
    Rocha E; López Borrasca A
    Rev Med Univ Navarra; 1974; 18(3-4):143-7. PubMed ID: 4471076
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of Hageman factor in disseminated intravascular coagulation induced by septicemia, neoplasia, or liver disease.
    Mason JW; Colman RW
    Thromb Diath Haemorrh; 1971 Oct; 26(2):325-31. PubMed ID: 5134485
    [No Abstract]   [Full Text] [Related]  

  • 20. Elevated prothrombin fragment 1 + 2 (F1 + 2) plasma levels may provide evidence of hypercoagulable states in gynecologic emergencies.
    Anand A
    Gynecol Oncol; 1994 Jul; 54(1):101. PubMed ID: 8020831
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.